GLUCOBAY DIN 02190893
Health Canada record
| Active ingredient(s) | ACARBOSE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A10BF01 ACARBOSE |
| Original market date | 02-Feb-1996 |
| Current status date | 10-Jul-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bayer Inc — licence 101029, currently licensed, last inspection rating C (2023-02-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ACARBOSE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02494078 | MAR-ACARBOSE | MARCAN PHARMACEUTICALS INC | Tablet | ACARBOSE 50 MG | Marketed |
| 02494086 | MAR-ACARBOSE | MARCAN PHARMACEUTICALS INC | Tablet | ACARBOSE 100 MG | Marketed |
| 02493780 | ACARBOSE TABLETS | STRIDES PHARMA CANADA INC | Tablet | ACARBOSE 50 MG | Dormant |
| 02493799 | ACARBOSE TABLETS | STRIDES PHARMA CANADA INC | Tablet | ACARBOSE 100 MG | Dormant |
| 02190885 | GLUCOBAY | BAYER INC | Tablet | ACARBOSE 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7993 | 2006-05-30 | Supplement to a New Drug Submission (SNDS) | PRODUCT NAME CHANGE FROM PRANDASE |
| 4851 | 1995-11-15 | New Drug Submission (NDS) |
International API supply for ACARBOSE
6 valid EDQM Certificates of Suitability from 6 holders. 7 active FDA Drug Master Files.
Request a quote for GLUCOBAY